Compare Stocks

Date Range: 

 i3 VerticalsQuinStreetViadCapitaOptimizeRx
SymbolNASDAQ:IIIVNASDAQ:QNSTNYSE:VVIOTCMKTS:CTAGYNASDAQ:OPRX
Price Information
Current Price$31.92$18.34$45.85$2.09$55.27
50-Day Moving Average$31.38$18.21$47.49$2.25$53.87
52-Week Low$20.25$11.14$13.94$2.09$13.84
52-Week High$35.99$25.99$52.00$2.60$63.98
MarketRank™
Overall Score2.72.52.00.72.5
Analysis Score2.43.52.50.03.5
Community Score4.44.15.03.64.5
Dividend Score0.00.00.00.00.0
Ownership Score5.02.51.70.02.5
Earnings & Valuation Score1.92.50.60.01.9
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/ABuy
Consensus Price Target$37.25$26.00$56.00N/A$71.00
% Upside from Price Target16.70% upside41.77% upside22.14% upsideN/A28.46% upside
Trade Information
Market Cap$1.03 billion$983.37 million$939.19 million$880.03 million$965.46 million
Beta1.610.912.041.290.65
Average Volume59,232171,288135,4926113,091
Sales & Book Value
Annual Revenue$150.13 million$490.34 million$415.43 million$4.27 billion$43.31 million
Price / Sales6.842.012.260.2122.29
Cashflow$1.20 per share$0.57 per shareN/A$0.87 per share$0.13 per share
Price / Cash26.6932.21N/A2.40421.75
Book Value$7.81 per share$4.93 per share$8.52 per share($0.25) per share$3.31 per share
Price / Book4.093.725.38-8.3616.70
Profitability
Net Income$-420,000.00$18.10 million$-374,090,000.00$17.98 million$-2,210,000.00
EPS$0.51$0.34($5.85)N/AN/A
Trailing P/E RatioN/A45.85N/A0.001,842.95
Forward P/E Ratio34.3273.3624.3980.10
P/E Growth2.37N/AN/AN/AN/A
Net Margins-1.95%3.98%-219.60%N/A1.35%
Return on Equity (ROE)6.18%7.91%-79.87%N/A0.82%
Return on Assets (ROA)3.08%5.31%-16.51%N/A0.72%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/A-75.00%N/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.63%N/A2.63%N/AN/A
Current Ratio0.55%1.74%0.89%0.49%18.51%
Quick Ratio0.55%1.74%0.81%0.49%18.52%
Ownership Information
Institutional Ownership Percentage62.47%86.76%89.32%N/A64.72%
Insider Ownership Percentage31.90%9.00%1.80%N/A6.50%
Miscellaneous
Employees7405921,69737,00071
Shares Outstanding32.16 million53.62 million20.48 million421.07 million17.47 million
Next Earnings Date8/9/2021 (Confirmed)8/4/2021 (Confirmed)8/5/2021 (Confirmed)N/A8/4/2021 (Confirmed)
OptionableNot OptionableOptionableOptionableNot OptionableNot Optionable
SourceHeadline
Douglas P. Baker Sells 3,000 Shares of OptimizeRx Co. (NASDAQ:OPRX) StockDouglas P. Baker Sells 3,000 Shares of OptimizeRx Co. (NASDAQ:OPRX) Stock
americanbankingnews.com - July 28 at 7:26 PM
OptimizeRx Corp. (OPRX) Reports Next Week: Wall Street Expects Earnings GrowthOptimizeRx Corp. (OPRX) Reports Next Week: Wall Street Expects Earnings Growth
finance.yahoo.com - July 28 at 7:21 PM
OptimizeRx (OPRX) Scheduled to Post Quarterly Earnings on WednesdayOptimizeRx (OPRX) Scheduled to Post Quarterly Earnings on Wednesday
americanbankingnews.com - July 28 at 9:01 AM
OptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET - The Bakersfield CalifornianOptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET - The Bakersfield Californian
bakersfield.com - July 28 at 8:27 AM
OptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET - Yahoo FinanceOptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET - Yahoo Finance
finance.yahoo.com - July 27 at 9:31 AM
OptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ETOptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET
finance.yahoo.com - July 27 at 9:31 AM
Insider Selling: OptimizeRx Co. (NASDAQ:OPRX) CFO Sells 3,000 Shares of StockInsider Selling: OptimizeRx Co. (NASDAQ:OPRX) CFO Sells 3,000 Shares of Stock
americanbankingnews.com - July 21 at 7:12 PM
OptimizeRx Co. (NASDAQ:OPRX) Insider Sells $666,602.28 in StockOptimizeRx Co. (NASDAQ:OPRX) Insider Sells $666,602.28 in Stock
americanbankingnews.com - July 21 at 7:12 PM
Insider Selling: OptimizeRx Co. (NASDAQ:OPRX) Director Sells 60,000 Shares of StockInsider Selling: OptimizeRx Co. (NASDAQ:OPRX) Director Sells 60,000 Shares of Stock
americanbankingnews.com - July 20 at 10:24 AM
$12.35 Million in Sales Expected for OptimizeRx Co. (NASDAQ:OPRX) This Quarter$12.35 Million in Sales Expected for OptimizeRx Co. (NASDAQ:OPRX) This Quarter
americanbankingnews.com - July 18 at 2:04 AM
OptimizeRx Co. (NASDAQ:OPRX) Expected to Announce Earnings of $0.07 Per ShareOptimizeRx Co. (NASDAQ:OPRX) Expected to Announce Earnings of $0.07 Per Share
americanbankingnews.com - July 16 at 9:14 PM
Form 8-K OptimizeRx Corp For: Jul 14 - StreetInsider.comForm 8-K OptimizeRx Corp For: Jul 14 - StreetInsider.com
streetinsider.com - July 15 at 12:16 AM
OptimizeRx Announces Agreement with a Top Pharmaceutical - GlobeNewswireOptimizeRx Announces Agreement with a Top Pharmaceutical - GlobeNewswire
globenewswire.com - July 14 at 2:15 PM
OptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for PatientsOptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients
finance.yahoo.com - July 14 at 9:14 AM
Fund Manager Ryan Jacob Takes On Cathie Woods ARK Funds With New ETF - BarronsFund Manager Ryan Jacob Takes On Cathie Wood's ARK Funds With New ETF - Barron's
barrons.com - July 13 at 6:13 PM
Q2 2021 Earnings Forecast for OptimizeRx Co. Issued By B. Riley (NASDAQ:OPRX)Q2 2021 Earnings Forecast for OptimizeRx Co. Issued By B. Riley (NASDAQ:OPRX)
americanbankingnews.com - July 12 at 1:08 AM
OptimizeRx Co. (NASDAQ:OPRX) CFO Sells $753,031.75 in StockOptimizeRx Co. (NASDAQ:OPRX) CFO Sells $753,031.75 in Stock
americanbankingnews.com - July 9 at 7:11 PM
Want $3,895 per Month in Social Security Benefits? Heres the Salary You Need - NasdaqWant $3,895 per Month in Social Security Benefits? Here's the Salary You Need - Nasdaq
nasdaq.com - July 9 at 8:20 AM
2 Top Small-Cap Stocks to Buy in July - Nasdaq2 Top Small-Cap Stocks to Buy in July - Nasdaq
nasdaq.com - July 8 at 12:47 PM
Zacks Investment Research Lowers OptimizeRx (NASDAQ:OPRX) to HoldZacks Investment Research Lowers OptimizeRx (NASDAQ:OPRX) to Hold
marketbeat.com - July 8 at 9:00 AM
2 Top Small-Cap Stocks to Buy in July - Motley Fool2 Top Small-Cap Stocks to Buy in July - Motley Fool
fool.com - July 8 at 7:47 AM
OptimizeRx (NASDAQ:OPRX) Shares Gap Down to $58.51OptimizeRx (NASDAQ:OPRX) Shares Gap Down to $58.51
americanbankingnews.com - July 7 at 12:37 PM
Returns On Capital Are Showing Encouraging Signs At OptimizeRx (NASDAQ:OPRX) - Yahoo FinanceReturns On Capital Are Showing Encouraging Signs At OptimizeRx (NASDAQ:OPRX) - Yahoo Finance
finance.yahoo.com - July 5 at 2:24 PM
Returns On Capital Are Showing Encouraging Signs At OptimizeRx (NASDAQ:OPRX)Returns On Capital Are Showing Encouraging Signs At OptimizeRx (NASDAQ:OPRX)
finance.yahoo.com - July 5 at 2:24 PM
President Biden holds wildfire prevention conference - Yahoo NewsPresident Biden holds wildfire prevention conference - Yahoo News
news.yahoo.com - July 2 at 8:01 AM
OptimizeRx Corp. (OPRX) Upgraded to Strong Buy: Heres Why - Yahoo FinanceOptimizeRx Corp. (OPRX) Upgraded to Strong Buy: Here's Why - Yahoo Finance
finance.yahoo.com - July 1 at 2:49 PM
DateCompanyBrokerageAction
7/26/2021i3 VerticalsMorgan Stanley
Initiated Coverage
5/26/2021ViadB. Riley
Initiated Coverage
5/7/2021OptimizeRxB. Riley
Boost Price Target
4/12/2021OptimizeRxRoyal Bank of Canada
Initiated Coverage
2/25/2021OptimizeRxB. Riley
Boost Price Target
2/25/2021OptimizeRxRoth Capital
Boost Price Target
2/10/2021i3 VerticalsKeyCorp
Boost Price Target
2/10/2021i3 VerticalsRaymond James
Boost Price Target
2/9/2021i3 VerticalsDA Davidson
Boost Price Target
2/4/2021QuinStreetBarrington Research
Boost Price Target
2/4/2021QuinStreetLake Street Capital
Boost Price Target
1/26/2021OptimizeRxLake Street Capital
Boost Price Target
1/14/2021i3 VerticalsRaymond James
Boost Price Target
1/7/2021OptimizeRxLake Street Capital
Boost Price Target
1/7/2021OptimizeRxRoth Capital
Boost Price Target
1/6/2021i3 VerticalsBTIG Research
Boost Price Target
1/6/2021i3 VerticalsBank of America
Downgrade
1/4/2021OptimizeRxB. Riley
Boost Price Target
12/21/2020i3 VerticalsPiper Sandler
Initiated Coverage
12/15/2020i3 VerticalsStephens
Initiated Coverage
12/11/2020QuinStreetBarrington Research
Boost Price Target
11/10/2020OptimizeRxLake Street Capital
Boost Price Target
11/10/2020OptimizeRxB. Riley
Boost Price Target
10/20/2020QuinStreetLake Street Capital
Boost Price Target
9/23/2020i3 VerticalsRaymond James
Upgrade
9/14/2020OptimizeRxRoth Capital
Boost Price Target
9/3/2020QuinStreetBarrington Research
Upgrade
8/17/2020QuinStreetBarrington Research
Reiterated Rating
8/12/2020i3 VerticalsRaymond James
Boost Price Target
8/12/2020i3 VerticalsKeyCorp
Boost Price Target
8/11/2020i3 VerticalsBTIG Research
Upgrade
8/6/2020OptimizeRxB. Riley
Boost Price Target
8/6/2020OptimizeRxLake Street Capital
Boost Price Target
6/26/2020CapitaJPMorgan Chase & Co.
Reiterated Rating
6/19/2020i3 VerticalsCowen
Boost Price Target
6/17/2020i3 VerticalsBTIG Research
Downgrade
6/8/2020OptimizeRxLake Street Capital
Boost Price Target
5/28/2020QuinStreetBarrington Research
Reiterated Rating
5/13/2020QuinStreetBarrington Research
Reiterated Rating
5/11/2020i3 VerticalsRaymond James
Lower Price Target
5/10/2020i3 VerticalsBTIG Research
Reiterated Rating
5/7/2020QuinStreetBarrington Research
Reiterated Rating
5/7/2020QuinStreetLake Street Capital
Lower Price Target
5/5/2020OptimizeRxB. Riley
Boost Price Target
4/16/2020QuinStreetBarrington Research
Downgrade
4/7/2020OptimizeRxB. Riley
Lower Price Target
3/31/2020ViadSidoti
Lower Price Target
3/23/2020i3 VerticalsBTIG Research
Upgrade
3/23/2020i3 VerticalsKeyCorp
Lower Price Target
3/5/2020ViadSidoti
Lower Price Target
2/28/2020i3 VerticalsDA Davidson
Upgrade
2/12/2020i3 VerticalsDA Davidson
Downgrade
2/11/2020i3 VerticalsBTIG Research
Downgrade
2/6/2020QuinStreetBarrington Research
Boost Price Target
2/6/2020QuinStreetBarrington Research
Reiterated Rating
1/16/2020i3 VerticalsBTIG Research
Reiterated Rating
1/3/2020OptimizeRxWilliam Blair
Initiated Coverage
12/30/2019OptimizeRxB. Riley
Lower Price Target
9/27/2019i3 VerticalsBank of America
Upgrade
9/5/2019i3 VerticalsBTIG Research
Set Price Target
8/15/2019QuinStreetBarrington Research
Lower Price Target
8/12/2019QuinStreetNorthland Securities
Reiterated Rating
8/9/2019QuinStreetStephens
Set Price Target
6/24/2019QuinStreetLake Street Capital
Initiated Coverage
5/16/2019QuinStreetBarrington Research
Reiterated Rating
3/7/2019QuinStreetSingular Research
Reiterated Rating
1/3/2019OptimizeRxWilliam Blair
Initiated Coverage
11/15/2018ViadJanney Montgomery Scott
Initiated Coverage
10/31/2018QuinStreetCraig Hallum
Reiterated Rating
10/4/2018QuinStreetWilliam Blair
Initiated Coverage
9/28/2018OptimizeRxRoth Capital
Boost Price Target
9/17/2018OptimizeRxLake Street Capital
Boost Price Target
8/8/2018OptimizeRxB. Riley
Boost Price Target
8/8/2018OptimizeRxLake Street Capital
Boost Price Target
8/7/2018QuinStreetStephens
Reiterated Rating
(Data available from 8/1/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.